13F-HR filed by DEERFIELD MANAGEMENT COMPANY, L.P.
DEERFIELD MANAGEMENT COMPANY, L.P. filed this 13F-HR for the quarter ended 2017-06-30, filed 2017-08-14, with 85 holding rows worth $1,874,767,000.
- Accession
- 0001140361-17-031950
- Filer
- CIK 1009258
- Filed
- 2017-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2017
A holdings report, 85 entries on the cover page, a total value of $1,874,767,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,874,767,000 with VALUE read as thousands by filing date, 13F file number 028-05366. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFlynn Management LLC028-11827
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AVEXIS INC | 05366U100 | COM | 2,308,130 | $189,636,000 | thousands by filing date | |
| HORIZON PHARMA PLC | G4617B105 | SHS | 8,998,413 | $106,811,000 | thousands by filing date | |
| NXSTAGE MEDICAL INC | 67072V103 | COMMON STOCK | 3,833,330 | $96,102,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 938,515 | $66,428,000 | thousands by filing date | |
| HORIZON PHARMA INVT LTD | 44052TAB7 | NOTE 2.500% 3/1 | 74,100,000 | $64,002,000 | thousands by filing date | principal |
| Gilead Sciences,Inc. | 375558103 | COM | 750,000 | $53,085,000 | thousands by filing date | call |
| MYLAN NV | N59465109 | SHS EURO | 1,367,119 | $53,072,000 | thousands by filing date | |
| Mallinckrodt Plc | G5785G107 | SHS | 1,178,605 | $52,813,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 315,417 | $51,899,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 961,147 | $50,508,000 | thousands by filing date | |
| ISIS PHARMACEUTICALS INC DEL | 464337AJ3 | NOTE 1.000%11/1 | 42,200,000 | $44,891,000 | thousands by filing date | principal |
| KEMPHARM INC | 488445AB3 | NOTE 5.500 2/0 | 75,000,000 | $44,250,000 | thousands by filing date | principal |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 3,655,494 | $40,320,000 | thousands by filing date | |
| TRINITY BIOTECH INVT LTD | 89643QAB4 | NOTE 4.000% 4/0 | 48,000,000 | $38,430,000 | thousands by filing date | principal |
| GLAUKOS CORP COM | 377322102 | Stock | 894,551 | $37,097,000 | thousands by filing date | |
| GW PHARMACEUTICALS PLC | 36197T103 | ADS | 359,983 | $36,088,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266SAB2 | NOTE 3.25011/0 | 40,500,000 | $34,309,000 | thousands by filing date | principal |
| INTERSECT ENT INC | 46071F103 | COM | 1,189,577 | $33,249,000 | thousands by filing date | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 1,729,268 | $33,081,000 | thousands by filing date | |
| LANNETT COMPANY INCORPORATED | 516012101 | COM | 1,523,957 | $31,089,000 | thousands by filing date | |
| NEVRO CORP | 64157FAA1 | BOND | 27,600,000 | $29,617,000 | thousands by filing date | principal |
| EDITAS MEDICINE INC | 28106W103 | COM | 1,709,400 | $28,684,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 376,308 | $28,009,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 665,197 | $23,754,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 419,000 | $23,535,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845PAA6 | NOTE 3.250% 7/0 | 22,500,000 | $21,983,000 | thousands by filing date | principal |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 1,060,000 | $21,052,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 1,268,945 | $20,417,000 | thousands by filing date | |
| LOXO ONCOLOGY INC | 548862101 | COM | 251,167 | $20,141,000 | thousands by filing date | |
| AETNA INC NEW | 00817Y108 | COM | 130,000 | $19,738,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 3,499,202 | $19,456,000 | thousands by filing date | |
| PATTERSON COS INC | 703395103 | COM | 393,262 | $18,464,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 247,841 | $18,130,000 | thousands by filing date | |
| STANDARD BIOTOOLS INC | 34385PAA6 | NOTE 2.750% 2/0 | 27,715,000 | $17,216,000 | thousands by filing date | principal |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 945,710 | $15,907,000 | thousands by filing date | |
| ADVANCED ACCELERATOR APPLIC SPONSORED ADS | 00790T100 | ADR | 392,904 | $15,339,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 187,501 | $14,348,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 75,182 | $14,144,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 746,841 | $13,891,000 | thousands by filing date | |
| AMERISOURCEBERGEN COR | 000307108 | COMMON | 1,975,347 | $13,689,000 | thousands by filing date | |
| AEGERION PHARMACEUTICALS INC | 00767EAB8 | NOTE 2.000 8/1 | 16,600,000 | $13,462,000 | thousands by filing date | principal |
| SOCIETAL CDMO INC | 75629F109 | COM | 1,901,685 | $13,369,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 552,859 | $13,230,000 | thousands by filing date | |
| EHEALTH INC | 28238P109 | COM | 690,348 | $12,979,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 562,236 | $11,869,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 756,822 | $11,731,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 419,453 | $11,644,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 2,279,780 | $11,627,000 | thousands by filing date | |
| AXOGEN INC | 05463X106 | COM | 674,428 | $11,297,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 509,022 | $10,796,000 | thousands by filing date | |
| NEOS THERAPEUTICS INC | 64052L106 | COM | 1,459,195 | $10,652,000 | thousands by filing date | |
| MOLINA HEALTHCARE INC | 60855R100 | COM | 151,665 | $10,492,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 203,000 | $10,286,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 375,000 | $10,170,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 662,369 | $10,002,000 | thousands by filing date | |
| ALLSCRIPTS HEALTHCARE SOLUTN | 01988PAD0 | NOTE 1.250% 7/0 | 9,671,000 | $9,830,000 | thousands by filing date | principal |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 1,094,305 | $9,630,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 119,000 | $9,506,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 104,000 | $9,090,000 | thousands by filing date | put |
| STEADYMED LTD | M84920103 | SHS | 1,441,913 | $9,084,000 | thousands by filing date | |
| NIVALIS THERAPEUTICS INC | 65481J109 | COM | 3,732,412 | $8,995,000 | thousands by filing date | |
| INVUITY INC | 46187J205 | COM NEW | 1,177,229 | $8,535,000 | thousands by filing date | |
| SELECT MED HLDGS CORP | 81619Q105 | COM | 504,632 | $7,746,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 416,729 | $7,030,000 | thousands by filing date | |
| ALIMERA SCIENCES INC | 016259103 | COM | 4,769,551 | $6,630,000 | thousands by filing date | |
| AXOVANT SCIENCES LTD | G0750W104 | COM | 239,180 | $5,547,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 216,761 | $5,419,000 | thousands by filing date | |
| MYOVANT SCIENCES LTD | G637AM102 | COMMON STOCK-FO | 400,685 | $4,688,000 | thousands by filing date | |
| SIERRA ONCOLOGY INC | 82640U107 | COM | 3,495,734 | $4,090,000 | thousands by filing date | |
| MANNKIND CORP COM NEW | 56400P706 | Stock | 2,702,403 | $3,810,000 | thousands by filing date | |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 817,435 | $3,793,000 | thousands by filing date | |
| AKARI THERAPEUTICS PLC | 00972G108 | ADR | 818,158 | $3,772,000 | thousands by filing date | |
| MYOKARDIA INC | 62857M105 | COM | 279,752 | $3,665,000 | thousands by filing date | |
| BIOSCRIP INC | 09069N108 | COM | 1,327,966 | $3,605,000 | thousands by filing date | |
| AGILE THERAPEUTICS INC | 00847L100 | COM | 955,109 | $3,582,000 | thousands by filing date | |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 247,872 | $3,478,000 | thousands by filing date | |
| KEMPHARM INC COM NEW | 488445107 | Stock | 704,612 | $2,818,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 500,000 | $2,780,000 | thousands by filing date | call |
| ARALEZ PHARMACEUTICALS INC | 03852X100 | COM | 1,644,583 | $2,220,000 | thousands by filing date | |
| PROTEON THERAPEUTICS INC | 74371L109 | COM | 1,224,899 | $1,868,000 | thousands by filing date | |
| OBALON THERAPEUTICS INC | 67424L100 | COM | 183,086 | $1,814,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 82,593 | $1,548,000 | thousands by filing date | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 117,647 | $1,054,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H104 | COM | 1,416,230 | $779,000 | thousands by filing date | |
| PROTEOSTASIS THERAPEUTICS IN | 74373B109 | COM | 17,251 | $81,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001140361-17-031950 | this filing | 2017-08-14 | acceptance time not in the bulk data set |